(VIANEWS) – The NASDAQ ended the session with Horizon Therapeutics jumping 6.24% to $88.46 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ jumped 1.65% to $11,815.23, after three successive sessions in a row of losses, on what was an all-around positive trend trading session today.
Today’s last reported volume for Horizon Therapeutics is 1700350, 12.08% below its average volume of 1934120.
Horizon Therapeutics’s last close was $83.26, 30.93% under its 52-week high of $120.54.
Horizon Therapeutics’s Sales
Horizon Therapeutics’s sales growth is 34.1% for the ongoing quarter and 177.8% for the next. The company’s growth estimates for the present quarter and the next is 14.8% and 4300%, respectively.
Horizon Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 3.23B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Horizon Therapeutics’s stock is considered to be overbought (>=80).
Horizon Therapeutics’s Stock Yearly Top and Bottom Value
Horizon Therapeutics’s stock is valued at $88.46 at 18:53 EST, way under its 52-week high of $120.54 and above its 52-week low of $83.42.
Horizon Therapeutics’s Moving Average
Horizon Therapeutics’s value is way below its 50-day moving average of $104.60 and way under its 200-day moving average of $104.49.
More news about Horizon Therapeutics (HZNP).